Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management

Pediatrics

Volumn 120, Issue 5, 2007, Pages

  Cheung, Amy H ^a   Zuckerbrot, Rachel A ^b,g   Jensen, Peter S ^c,f   Ghalib, Kareem ^b,g   Laraque, Danielle ^d   Stein, Ruth E K ^e   Levitt, Anthony ^a   Birmaher, Boris ^h   Campo, John ⁱ   Clarke, Greg ^j   Davis, Dave ^a   Diaz, Angela ^d,v   Dietrich, Allen ^k   Emslie, Graham ^l   Ewigman, Bernard ^m   Fombonne, Eric ^n,y   Glied, Sherry ^g   Hoagwood, Kimberly Eaton ^g   Homer, Charles ^o   Kaufman, Miriam ^p   Kelleher, Kelly J ^i,v   Kutcher, Stanley ^q   Malus, Michael ^n,ac   Perrin, James ^r,v   Pincus, Harold ^b   Reiss Brennan, Brenda ^s   Sacks, Diane ^t,v   Waslick, Bruce ^u,w   Fassler, David ^x   McIntyre, James ^z   Garber, Judy ^aa   Wolfe, Vicky ^ab   Renaud, Johanne ^ad   Ebner, Debbie ^ae   Friedman, Stanford ^af   Stancin, Terry ^af   Salisbury, Kathryn ^ag   Faenza, Michael ^ah   Bergeson, Susan ^s   Gruttadaro, Darcy ^ai   Spencer, Sandra ^s   Hawkins Walsh, Elizabeth ^aj   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c REsource for Advancing Children's Health   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f REACH Institute   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j KAISER PERMANENTE   (United States)

^k DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m UNIVERSITY OF CHICAGO   (United States)

ⁿ MCGILL UNIVERSITY   (Canada)

^o National Initiative for Children's Healthcare Quality   (United States)

^p HOSPITAL FOR SICK CHILDREN   (Canada)

^q DALHOUSIE UNIVERSITY   (Canada)

^r HARVARD MEDICAL SCHOOL   (United States)

^s National Initiative for Children's Healthcare Quality ^*

^t CANADIAN PAEDIATRIC SOCIETY   (Canada)

^u BAYSTATE HEALTH   (United States)

^v AMERICAN ACADEMY OF PEDIATRICS   (United States)

^w AMERICAN MEDICAL ASSOCIATION   (United States)

^x American Academy of Child and Adolescent Psychiatry   (United States)

^y Canadian Psychiatric Association   (Canada)

^z AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^aa AMERICAN PSYCHOLOGICAL ASSOCIATION   (United States)

^ab Canadian Psychological Association   (Canada)

^ac Professional Development and Practice Support   (Canada)

^ad Canadian Association for Adolescent Health   (Canada)

^ae Society for Adolescent Medicine   (United States)

^af Society for Developmental and Behavioral Pediatrics

^ag Mental Health Association of New York City   (United States)

^ah Mental Health America   (United States)

^ai National Alliance on Mental Illness   (United States)

^aj National Association for Pediatric Nurse Practitioners   (United States)

more..

Author keywords

Adolescents; Depression; Guidelines; Primary care

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; COGNITIVE THERAPY; CONSENSUS DEVELOPMENT; CONSULTATION; DEPRESSION; DRUG SAFETY; EVIDENCE BASED PRACTICE; HUMAN; OUTCOMES RESEARCH; PATIENT MONITORING; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; SUICIDAL BEHAVIOR;

ADOLESCENT; DEPRESSIVE DISORDER; DISEASE MANAGEMENT; HUMANS; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 36048957139     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1395     Document Type: Article

References (91)

1. Fleming JE, Offord DR, Boyle MHP. Prevalence of childhood and adolescent depression in the community. Ontario Child Health Study. Br J Psychiatry. 1989;155:647-654
2. Shaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry. 1996;53:339-348
3. Garrison CZ, Addy CL, Jackson KL, McKeown RE, Waller JL. Major depressive disorder and dysthymia in young adolescents. Am J Epidemiol. 1992;135:792-802
4. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993;102:133-144
5. Whitaker A, Johnson J, Shaffer D, et al. Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population. Arch Gen Psychiatry. 1990;47:487-496
6. Johnson JG, Harris ES, Spitzer RL, Williams JB. The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30:196-204
7. Bartlett JA, Schleifer SJ, Johnson RL, Keller SE. Depression in inner city adolescents attending an adolescent medicine clinic. J Adolesc Health. 1991;12:316-318
8. Schubiner H, Robin A. Screening adolescents for depression and parent-teenager conflict in an ambulatory medical setting: a preliminary investigation. Pediatrics. 1990;85:813-818
9. Winter LB, Steer RA, Jones-Hicks L, Beck AT. Screening for major depression disorders in adolescent medical outpatients with the Beck Depression Inventory for Primary Care. J Adolesc Health. 1999;24:389-394
10. Rifkin A, Wortman R, Reardon G, Siris SG. Psychotropic medication in adolescents: a review. J Clin Psychiatry. 1986;47:400-408
11. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 2001;49:1002-1014
12. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med. 2002;156:592-598
13. Rushton JL, Clark SJ, Freed GL. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics. 2000;105(6). Available at: www.pediatrics.org/cgi/content/full/105/6/e82
14. Zito JM, Safer DJ, DosReis S, et al. Rising prevalence of antidepressants among US youths. Pediatrics. 2002;109:721-727
15. Costello EJ, Edelbrock C, Costello AJ, Dulcan MK, Burns BJ, Brent D. Psychopathology in pediatric primary care: the new hidden morbidity. Pediatrics. 1988;82:415-424
16. Briggs-Gowan MJ, Horwitz SM, Schwab-Stone ME, Leventhal JM, Leaf PJ. Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry. 2000;39:841-849
17. Jensen PS. Closing the evidence-based treatment gap for children's mental health services: what we know versus what we do. Emotional Behav Disord Youth. 2002;2:43-50
18. Olin SC, Hoagwood K. The Surgeon General's national action agenda on children's mental health. Curr Psychiatry Rep. 2002;4:101-107
19. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 1998;37(10 suppl):63S-83S
20. American Academy of Pediatrics, Committee on Adolescence. Suicide and suicide attempts in adolescents. Pediatrics. 2000;105:871-874
21. Zuckerbrot RA, Cheung AH, Jensen PS, Stein REK, Laraque D; GLAD PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): part I - identification, assessment, and initial management. Pediatrics. 2007;120(5). Available at: www.pediatrics.org/cgi/content/full/120/5/e1299
22. Stein REK, Zitner LE, Jensen PS. Interventions for adolescent depression in primary care. Pediatrics. 2006;118:669-682
23. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry. 2005;46:735-754
24. Bower P, Garralda E, Kramer T, Harrington R, Sibbald B. The treatment of child and adolescent mental health problems in primary care: a systematic review. Fam Pract. 2001;18:373-382
25. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332-339
26. Walker Z, Townsend J, Oakley L, et al. Health promotion for adolescents in primary care: randomised controlled trial. BMJ. 2002;325:524
27. Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA. 2005;293:311-319
28. Mufson L, Weissman MM, Moreau D, Garfinkel R. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 1999;56:573-579
29. Clarke G, Debar L, Lynch F, et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005;44:888-898
30. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441-445
31. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000;320:26-30
32. Oxman TE, Barrett JE, Sengupta A, et al. Status of minor depression or dysthymia in primary care following a randomized controlled treatment. Gen Hosp Psychiatry. 2001;23:301-310
33. Bass JL, Christoffel KK, Widome M, et al. Childhood injury prevention counseling in primary care settings: a critical review of the literature. Pediatrics. 1993;92:544-550
34. Stroul BA, Friedman R, eds. A System of Care for Children and Youth With Severe Emotional Disturbances. Washington, DC: Georgetown University Child Development Center, CASSP, Technical Assistance Center; 1986
35. Bickman L, Guthrie PR, Foster EM, et al. Evaluating Managed Mental Health Services: The Fort Bragg Experiment. Nashville, TN: Vanderbilt University; 1995
36. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807-820
37. Simeon JG, Dinicola VF, Ferguson HB, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:791-795
38. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004;161:1079-1083
39. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40:762-772
40. Mandoki MW, Tapia MR, Tapia MA, Sumner GS, Parker JL. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull. 1997;33:149-154
41. Bridge JA, Salary CB, Birmaher B, Asare AG, Brent DA. The risks and benefits of antidepressant treatment for youth depression. Ann Med. 2005;37:404-412
42. GlaxoSmithKline. Paroxetine and pediatric and adolescent patients. Available at: www.gsk.com/media/paroxetine.htm. Accessed January 3, 2007
43. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents [published correction appears in BMJ. 2004;328:1170]. BMJ. 2004;328:879-883
44. Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60:978-982
45. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry. 2006;163:1898-1904
46. Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. 2003;326:1008
47. Helgason T, Tomasson H, Zoega T. Antidepressants and public health in Iceland: time series analysis of national data. Br J Psychiatry. 2004;184:157-162
48. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005;62:165-172
49. Ludwig J, Marcotte DE. Anti-depressants, suicide, and drug regulation. J Policy Anal Manage. 2005;24:249-272
50. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs. 2004;18:1119-1132
51. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004;292:338-343
52. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and nonfatal self harm in first episode depression: nested case-control study. BMJ. 2005;330:389
53. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41-47
54. Reinecke MA, Ryan NE, DuBois DL. Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 1998;37:26-34
55. Harrington R, Campbell F, Shoebridge P, Whittaker J. Metaanalysis of CBT for depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37:1005-1007
56. Compton SN, March JS, Brent D, Albano AM, Weersing R, Curry J. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43:930-959
57. Puskar K, Sereika S, Tusaie-Mumford K. Effect of the Teaching Kids to Cope (TKC) program on outcomes of depression and coping among rural adolescents. J Child Adolesc Psychiatr Nurs. 2003;16:71-80
58. Kerfoot M, Harrington R, Harrington V, Rogers J, Verduyn C. A step too far? randomized trial of cognitive-behavior therapy delivered by social workers to depressed adolescents. Eur Child Adolesc Psychiatry. 2004;13:92-99
59. Rohde P, Clarke GN, Mace DE, Jorgensen JS, Seeley JR. An efficacy/effectiveness study of cognitive-behavioral treatment for adolescents with comorbid major depression and conduct disorder. J Am Acad Child Adolesc Psychiatry. 2004;43:660-668
60. Rosselló J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol. 1999;67:734-745
61. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 2004;61:577-584
62. Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y, Durn BL. Efficacy and safety of venlafaxine ER in children and adolescents with major depressive disorder. Poster presented at: the American Psychiatric Association Annual Meeting: May 1-6 2004; New York, NY
63. Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004;43:1397-1405
64. Brent DA, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry. 1997;54:877-885
65. Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry. 1996;37:737-746
66. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial [published correction appears in JAMA. 2000;283:3204]. JAMA. 2000;283:212-220
67. Lang AJ, Norman GJ, Casmar PV. A randomized trial of a brief mental health intervention for primary care patients. J Consult Clin Psychol. 2006;74:1173-1179
68. Unützer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-2845
69. Katon WJ, Von Korff M, Lin EH, et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61:1042-1049
70. Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004;292:935-942
71. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-554
72. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-932
73. Harrington R, Whittaker J, Shoebridge P, Campbell F. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. BMJ. 1998;316:1559-1563
74. Rohde P, Lewinsohn PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry. 1997;154:1593-1598
75. Simon GE, Revicki D, VonKorff M. Telephone assessment of depression severity. J Psychiatr Res.1993;27:247-252
76. Greenhill LL, Vitiello B, Riddle MA, et al. Review of safety assessment methods used in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2003;42:627-633
77. Greenhill LL, Vitiello B, Fisher P, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2004;43:1488-1496
78. Kennedy SH, Lam RW, Cohen NL, Ravindran AV; CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders: IV. Medications and other biological treatments. Can J Psychiatry. 2001;46(suppl 1):38S-58S
79. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289:3145-3151
80. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241-247
81. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry. 1999;56:1109-1115
82. Zuckerbrot RA, Maxon L, Pagar D, Davies M, Fisher PW, Shaffer D. Adolescent depression screening in primary care: feasibility and acceptability. Pediatrics. 2007;119:101-108
83. Margolis PA, Stevens R, Bordley WC, et al. From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children. Pediatrics. 2001;108(3). Available at: www.pediatrics.org/cgi/content/full/108/3/e42
84. Rosenblatt A, Attkisson CC, Fernandez AJ. Integrating systems of care in California for youth with severe emotional disturbance, II: initial group home expenditure and utilization findings from the California AB377 evaluation project. J Child Fam Stud. 1992;1:263-286
85. Bickman L, Lambert EW, Summerfelt WT, Heflinger CA. Rejoinder to questions about the Fort Bragg evaluation. J Child Fam Stud. 1996;5:197-206
86. Bickman L, Noser K, Summerfelt WT. Long-term effects of a system of care on children and adolescents. J Behav Health Serv Res. 1999;26:185-202
87. Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157:408-416
88. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995;153:1423-1431
89. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037
90. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003;290:1033-1041
91. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006;45(3):280-288